| __timestamp | Ionis Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 205018000 |
| Thursday, January 1, 2015 | 322292000 | 392709000 |
| Friday, January 1, 2016 | 344320000 | 299694000 |
| Sunday, January 1, 2017 | 374644000 | 397061000 |
| Monday, January 1, 2018 | 1820000 | 434100000 |
| Tuesday, January 1, 2019 | 4000000 | 782200000 |
| Wednesday, January 1, 2020 | 12000000 | 1119900000 |
| Friday, January 1, 2021 | 11000000 | 2437500000 |
| Saturday, January 1, 2022 | 14000000 | 1560400000 |
| Sunday, January 1, 2023 | 9133000 | 1815800000 |
| Monday, January 1, 2024 | 11215000 | 1970500000 |
Infusing magic into the data realm
In the competitive landscape of biopharmaceuticals, understanding cost structures is pivotal. Regeneron Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. have showcased intriguing trends in their cost of revenue over the past decade. From 2014 to 2023, Regeneron has seen a staggering 785% increase in its cost of revenue, peaking in 2021. This reflects its aggressive expansion and investment in cutting-edge therapies. In contrast, Ionis Pharmaceuticals experienced a more volatile trajectory, with a notable dip in 2018, followed by a gradual recovery. By 2023, Ionis's cost of revenue was approximately 4% of Regeneron's, highlighting differing operational scales and strategies. These insights underscore the dynamic nature of financial management in the biopharma sector, where strategic investments and cost efficiency are key to sustaining growth and innovation.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored